Nuveen Asset Management, LLC Astrazeneca PLC Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 475,222 shares of AZN stock, worth $35.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

475,222

Previous 2,255,580 78.93%

Holding current value

$35.4 Million

Previous $176 Million 82.28%

% of portfolio

0.01%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $113 Million - $142 Million	-1,780,358 Reduced 78.93%	475,222 $31.1 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $45.3 Million - $51.7 Million	590,544 Added 35.47%	2,255,580 $176 Million
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $2.51 Million - $3.04 Million	-37,576 Reduced 2.21%	1,665,036 $130 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $119 Million - $136 Million	-1,948,558 Reduced 53.37%	1,702,612 $115 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $104 Million - $116 Million	-1,675,192 Reduced 31.45%	3,651,170 $246 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $102 Million - $113 Million	-1,576,674 Reduced 22.84%	5,326,362 $361 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $9.17 Million - $9.94 Million	-131,152 Reduced 1.86%	6,903,036 $494 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $66.3 Million - $75.2 Million	-1,050,494 Reduced 12.99%	7,034,188 $488 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $34.3 Million - $44.6 Million	633,004 Added 8.49%	8,084,682 $548 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $3.97 Million - $10.2 Million	-74,846 Reduced 0.99%	7,451,678 $409 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $33.9 Million - $40.7 Million	-572,654 Reduced 7.07%	7,526,524 $497 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $17.7 Million - $21.3 Million	317,164 Added 4.08%	8,099,178 $537 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $25.6 Million - $30.3 Million	-474,462 Reduced 5.75%	7,782,014 $453 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $157 Million - $171 Million	2,820,586 Added 51.89%	8,256,476 $496 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $88.6 Million - $110 Million	1,830,576 Added 50.77%	5,435,890 $326 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $31.4 Million - $36.3 Million	666,137 Added 22.66%	3,605,314 $179 Million
Q4 2020 May 17, 2021	BUY	$48.52 - $58.02 $62.4 Million - $74.6 Million	1,285,852 Added 77.77%	2,939,177 $147 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $25.5 Million - $30.4 Million	-524,695 Reduced 24.09%	1,653,325 $82.7 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $15 Million - $17.2 Million	-282,183 Reduced 11.47%	2,178,020 $119 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $13.6 Million - $17.4 Million	314,451 Added 14.65%	2,460,203 $130 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $20.8 Million - $28.3 Million	550,742 Added 34.53%	2,145,752 $95.8 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $27.9 Million - $33.1 Million	656,269 Added 69.91%	1,595,010 $79.5 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $19.3 Million - $21.9 Million	482,147 Added 105.6%	938,741 $41.8 Million
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $17 Million - $19 Million	456,594 New	456,594 $18.8 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $233,031 - $258,900	-7,068 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $4,524 - $4,903	141 Added 2.04%	7,068 $0
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $200,605 - $235,518	6,927	6,927 $235,000

Others Institutions Holding AZN

# of Institutions

1,355

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Astrazeneca PLC Transaction History